Screening for fetal growth restriction with universal third trimester ultrasonography in nulliparous women in the Pregnancy Outcome Prediction (POP) study: a prospective cohort study

Ulla Sovio, Ian R White, Alison Dacey, Dharmintra Pasupathy, Gordon C S Smith, Ulla Sovio, Ian R White, Alison Dacey, Dharmintra Pasupathy, Gordon C S Smith

Abstract

Background: Fetal growth restriction is a major determinant of adverse perinatal outcome. Screening procedures for fetal growth restriction need to identify small babies and then differentiate between those that are healthy and those that are pathologically small. We sought to determine the diagnostic effectiveness of universal ultrasonic fetal biometry in the third trimester as a screening test for small-for-gestational-age (SGA) infants, and whether the risk of morbidity associated with being small differed in the presence or absence of ultrasonic markers of fetal growth restriction.

Methods: The Pregnancy Outcome Prediction (POP) study was a prospective cohort study of nulliparous women with a viable singleton pregnancy at the time of the dating ultrasound scan. Women participating had clinically indicated ultrasonography in the third trimester as per routine clinical care and these results were reported as usual (selective ultrasonography). Additionally, all participants had research ultrasonography, including fetal biometry at 28 and 36 weeks' gestational age. These results were not made available to participants or treating clinicians (universal ultrasonography). We regarded SGA as a birthweight of less than the 10th percentile for gestational age and screen positive for SGA an ultrasonographic estimated fetal weight of less than the 10th percentile for gestational age. Markers of fetal growth restriction included biometric ratios, utero-placental Doppler, and fetal growth velocity. We assessed outcomes for consenting participants who attended research scans and had a livebirth at the Rosie Hospital (Cambridge, UK) after the 28 weeks' research scan.

Findings: Between Jan 14, 2008, and July 31, 2012, 4512 women provided written informed consent of whom 3977 (88%) were eligible for analysis. Sensitivity for detection of SGA infants was 20% (95% CI 15-24; 69 of 352 fetuses) for selective ultrasonography and 57% (51-62; 199 of 352 fetuses) for universal ultrasonography (relative sensitivity 2·9, 95% CI 2·4-3·5, p<0·0001). Of the 3977 fetuses, 562 (14·1%) were identified by universal ultrasonography with an estimated fetal weight of less than the 10th percentile and were at an increased risk of neonatal morbidity (relative risk [RR] 1·60, 95% CI 1·22-2·09, p=0·0012). However, estimated fetal weight of less than the 10th percentile was only associated with the risk of neonatal morbidity (pinteraction=0·005) if the fetal abdominal circumference growth velocity was in the lowest decile (RR 3·9, 95% CI 1·9-8·1, p=0·0001). 172 (4%) of 3977 pregnancies had both an estimated fetal weight of less than the 10th percentile and abdominal circumference growth velocity in the lowest decile, and had a relative risk of delivering an SGA infant with neonatal morbidity of 17·6 (9·2-34·0, p<0·0001).

Interpretation: Screening of nulliparous women with universal third trimester fetal biometry roughly tripled detection of SGA infants. Combined analysis of fetal biometry and fetal growth velocity identified a subset of SGA fetuses that were at increased risk of neonatal morbidity.

Funding: National Institute for Health Research, Medical Research Council, Sands, and GE Healthcare.

Copyright © 2015 Sovio et al. Open Access article distributed under the terms of CC BY. Published by Elsevier Ltd.. All rights reserved.

Figures

Figure 1
Figure 1
Study profile
Figure 2
Figure 2
Stratified analyses of the risk of the neonatal composite adverse outcome associated with diagnosis of small-for-gestational-age infants Diagnosis of infants by universal ultrasonography in relation to indicators of fetal growth restriction. The five previously described indices of fetal growth restriction were classified as the extreme decile associated with fetal growth restriction (highest or lowest, as appropriate) compared with the other nine deciles in the cohort. Points are relative risks of neonatal morbidity associated with an ultrasonic diagnosis of a small-for-gestational-age infant at the last scan before birth. p values are a Mantel-Haenszel test calculation of interaction (ie, testing the hypothesis that the association between diagnosis of a small-for-gestation-age infant and neonatal morbidity varies in the two strata). Interactions tested using logistic regression showed almost identical p values. AC=abdominal circumference. FL=femur length. HC=head circumference.

References

    1. RCOG . Green-top guideline no. 31: the investigation and management of the small-for-gestational-age fetus. Royal College of Obstetricians and Gynaecologists Press; London: 2013.
    1. American College of Obstetricians and Gynecologists ACOG practice bulletin no 101: ultrasonography in pregnancy. Obstet Gynecol. 2009;113:451–461.
    1. NICE. National Collaborating Centre for Women's and Children's Health . NICE guideline: antenatal care. Royal College of Obstetricians and Gynaecologists Press; London: 2008.
    1. Bais JM, Eskes M, Pel M, Bonsel GJ, Bleker OP. Effectiveness of detection of intrauterine growth retardation by abdominal palpation as screening test in a low risk population: an observational study. Eur J Obstet Gynecol Reprod Biol. 2004;116:164–169.
    1. Sparks TN, Cheng YW, McLaughlin B, Esakoff TF, Caughey AB. Fundal height: a useful screening tool for fetal growth? J Matern Fetal Neonatal Med. 2011;24:708–712.
    1. Chauhan SP, Rouse DJ, Ananth CV. Screening for intrauterine growth restriction in uncomplicated pregnancies: time for action. Am J Perinatol. 2013;30:33–39.
    1. De Reu PA, Oosterbaan HP, Smits LJ, Nijhuis JG. Avoidable mortality in small-for-gestational-age children in the Netherlands. J Perinat Med. 2010;38:311–418.
    1. Stacey T, Thompson JM, Mitchell EA, Zuccollo JM, Ekeroma AJ, McCowan LM. Antenatal care, identification of suboptimal fetal growth and risk of late stillbirth: findings from the Auckland Stillbirth Study. Aust N Z J Obstet Gynaecol. 2012;52:242–247.
    1. Bricker L, Neilson JP, Dowswell T. Routine ultrasound in late pregnancy (after 24 weeks' gestation) Cochrane Database Syst Rev. 2008;4 CD001451.
    1. Smith GC. Researching new methods of screening for adverse pregnancy outcome: lessons from pre-eclampsia. PLoS Med. 2012;9:e1001274.
    1. Pasupathy D, Dacey A, Cook E, Charnock-Jones DS, White IR, Smith GC. Study protocol. A prospective cohort study of unselected primiparous women: the pregnancy outcome prediction study. BMC Pregnancy Childbirth. 2008;8:51.
    1. NICE . Guideline development methods: information for national collaborating centres and guideline developers. National Institute for Health and Care Excellence; London: 2004.
    1. Loughna P, Chitty L, Evans AL, Chudleigh T. Fetal size and dating: charts recommended for clinical obstetric practice. Ultrasound. 2009;17:161–167.
    1. Bhide A, Acharya G, Bilardo CM. ISUOG practice guidelines: use of Doppler ultrasonography in obstetrics. Ultrasound Obstet Gynecol. 2013;41:233–239.
    1. Hadlock FP, Harrist RB, Sharman RS, Deter RL, Park SK. Estimation of fetal weight with the use of head, body, and femur measurements—a prospective study. Am J Obstet Gynecol. 1985;151:333–337.
    1. Hadlock FP, Harrist RB, Martinez-Poyer J. In utero analysis of fetal growth: a sonographic weight standard. Radiology. 1991;181:129–133.
    1. NICE. National Collaborating Centre for Women's and Children's Health . NICE Guideline: diabetes in pregnancy: management of diabetes and its complications from pre-conception to the postnatal period. Royal College of Obstetricians and Gynaecologists Press; London: 2008.
    1. NICE. National Collaborating Centre for Women's and Children's Health . NICE Guideline: hypertension in pregnancy: the management of hypertensive disorders during pregnancy. Royal College of Obstetricians and Gynaecologists Press; London: 2010.
    1. Freeman JV, Cole TJ, Chinn S, Jones PR, White EM, Preece MA. Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child. 1995;73:17–24.
    1. ACOG Committee on Obstetric Practice ACOG Committee opinion no. 348, November 2006: Umbilical cord blood gas and acid-base analysis. Obstet Gynecol. 2006;108:1319–1322.
    1. Gardosi J, Mongelli M, Wilcox M, Chang A. An adjustable fetal weight standard. Ultrasound Obstet Gynecol. 1995;6:168–174.
    1. Kosinski AS. A weighted generalized score statistic for comparison of predictive values of diagnostic tests. Stat Med. 2013;32:964–977.
    1. Gu W, Pepe MS. Estimating the capacity for improvement in risk prediction with a marker. Biostatistics. 2009;10:172–186.
    1. Noble M, McLennan D, Wilkinson K, Whitworth A, Barnes H, Dibben C. The English indices of deprivation 2007. Department for Communities and Local Government; London: 2008.
    1. Papageorghiou AT, Ohuma EO, Altman DG, for the International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st) International standards for fetal growth based on serial ultrasound measurements: the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project. Lancet. 2014;384:869–879.
    1. Pilliod RA, Cheng YW, Snowden JM, Doss AE, Caughey AB. The risk of intrauterine fetal death in the small-for-gestational-age fetus. Am J Obstet Gynecol. 2012;207:318–416.
    1. Pasupathy D, Wood AM, Pell JP, Fleming M, Smith GC. Rates of and factors associated with delivery-related perinatal death among term infants in Scotland. JAMA. 2009;302:660–668.
    1. Bukowski R, Burgett AD, Gei A, Saade GR, Hankins GD. Impairment of fetal growth potential and neonatal encephalopathy. Am J Obstet Gynecol. 2003;188:1011–1015.
    1. McIntyre S, Blair E, Badawi N, Keogh J, Nelson KB. Antecedents of cerebral palsy and perinatal death in term and late preterm singletons. Obstet Gynecol. 2013;122:869–877.
    1. MacKay DF, Smith GC, Dobbie R, Pell JP. Gestational age at delivery and special educational need: retrospective cohort study of 407,503 schoolchildren. PLoS Med. 2010;7:e1000289.
    1. Barker DJ. Adult consequences of fetal growth restriction. Clin Obstet Gynecol. 2006;49:270–283.
    1. Moraitis AA, Wood AM, Fleming M, Smith GC. Birth weight percentile and the risk of term perinatal death. Obstet Gynecol. 2014;124:274–283.

Source: PubMed

Подписаться